长期的肝炎相关论文
瞄准：在长期的肝炎 B 估计外部 T 淋巴细胞子集响应 adefovir dipivoxil monotherapy 的病毒(HBV ) 感染，和他们的动力学。方法：比例......
Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or mi
AIM To develop a non-invasive model to evaluate significant fibrosis and cirrhosis by investigating the association betw......
Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian chil
AIM To investigate the impact of IL28 B and OAS gene polymorphisms on interferon treatment responses in children with ch......
AIM To investigate the associations of different types of pre-S deletions with hepatitis B virus(HBV) genotypes.METHODS ......
Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine a
AIM To determine incidence and clinical biomarkers of marked necroinflammation and fibrosis characteristics among chroni......
The Predictive Value of Baseline HBs Ag Level and Early Response for HBs Ag Loss in Patients with HB
ObjectiveTo 在 121 全部的 pegylated 干扰素 alpha-2a treatment.MethodsA 期间与 HBeAg 积极的长期的肝炎 B 在病人为 HBsAg 损......
AIM To survey the efficacy and safety of dual therapy with daclatasvir and asunaprevir in the elderly hepatitis C virus(......
当前，尽管 lamivudine (打) 有一个低基因障碍，仅仅 interferon-alpha 并且打作为在有长期的肝炎 B (CHB ) 的孩子的首要的治疗可得......
Telbivudine vs tenofovir in hepatitis B e antigen-negative chronic hepatitis B patients: OPTIMA road
AIM To make efficacy and safety comparison of telbivudineraodmap and tenofovir-roadmap in hepatitis B e antigen(HBe Ag)-......
Seroprevalence of hepatitis B surface antigen in pregnant women attending antenatal clinic in Honiar
AIM To determine the seroprevalence of hepatitis B surface antigen(HBsAg) among pregnant women attending antenatal clini......
On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chr
AIM To investigate potential predictors for treatment response to nucleos(t)ide analogues(NAs) in hepatitis B e antigen(......
AIM To evaluate the long-term treatment outcomes of tenofovir therapy in patients in a real world Australian tertiary ca......
Oral nucleoside/nucleotide analogues(NAs) are currently the backbone of chronic hepatitis B(CHB) infection treatment. Th......
